Company intelligence / Profile preview

PhystechBIO

Dolgoprudny, Moscow Oblast, Russiaptbio.ru ↗

Ownership: Private
Development stage: Commercial

Overview

PhystechBIO is a private investment and management company specializing in the implementation of new physical methods and technologies within the life sciences sector. The company focuses on supporting innovation at the intersection of physics, technology, and biology. There is no evidence that it develops its own clinical-stage therapeutics or has reported clinical results[1].

Industry: Investors

Drug pipeline

3 assets

SONYA

Commercial

Indications: Insomnia, Sleep disorders

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on PhystechBIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PhystechBIO.

Explore the full profile